[Decrease in motor activity in C57Bl/6 mice as affected by lymphocytes taken from animals with Parkinsonian syndrome induced by 1,2,3,6-tetrahydropyridine (MPTP)].

G N Kryzhanovskiĭ; T V Davydova; V G Fomina; K D Pletsityĭ; V A Evseev; N A Krupina; V G Kucherianu

Home/Archive/PubMed

PubMed · 8204836

[Decrease in motor activity in C57Bl/6 mice as affected by lymphocytes taken from animals with Parkinsonian syndrome induced by 1,2,3,6-tetrahydropyridine (MPTP)].

G N Kryzhanovskiĭ·T V Davydova·V G Fomina·K D Pletsityĭ·V A Evseev·N A Krupina·V G Kucherianu

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Animals B-Lymphocytes Immunotherapy, Adoptive Male Mice Mice, Inbred C57BL Motor Activity Parkinson Disease, Secondary Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

G N Kryzhanovskiĭ, T V Davydova, V G Fomina, K D Pletsityĭ, V A Evseev, N A Krupina, V G Kucherianu. 1994. [Decrease in motor activity in C57Bl/6 mice as affected by lymphocytes taken from animals with Parkinsonian syndrome induced by 1,2,3,6-tetrahydropyridine (MPTP)].. https://pubmed.ncbi.nlm.nih.gov/8204836/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.

Evidence is accumulating that norepinephrine depletion enhances the neurotoxic effect of the parkinsonism inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this study we investigated whether norepinephrine loss potentiates methamphetamine-induced striatal dopamine depletion. Injection of C57BL/6N mice with methamphetamine (2 x 5 mg/kg i.p., at 2-h intervals) produced only a partial (50%) striatal dopamine depletion 7 days after drug administration. Pretreatment with the selective noradrenergic neurotoxin N-(-2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4; 50 mg/kg i.p.) enhanced methamphetamine-induced striatal dopamine depletion by 86%, without decreasing striatal dopamine levels when injected alone. Our results extend previous findings obtained with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine in DSP-4-pretreated mice.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine↗

PubMed1995

Alteration of corticotropin-releasing factor immunoreactivity in MPTP-treated rats.

A decrease of corticotropin-releasing factor (CRF) concentration has been reported in patients with Parkinson's disease (PD). The present study further examined the role of CRF in an animal model of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Results indicated that both subchronic (2 days) and chronic (7 days) MPTP treatments decreased the number of CRF immunoreactive neurons in both the paraventricular nucleus (PVN) of the hypothalamus and the central nuelcus of the amygdala (ACN). This effect lasted for almost a month after withdrawal of chronic MPTP injections. In addition, nomifensine pretreatment protected against MPTP's toxicity on DA neurons, as assessed by tyrosine hydroxylase immunoreactivity in the substantia nigra. However, the same treatment did not prevent the toxicity of MPTP on CRF neurons. Further, no significant difference was notable in the number of CRF immunoreactive neurons between normal young adult and normal middle-aged rats in both the PVN and the ACN. These results suggest that MPTP also produces a neurotoxicity on CRF neurons, and this effect is not secondary to MPTP's effect on DA neurons. Besides, altered CRF neuronal activity is involved in the process of pathological ageing, but not physiological ageing. Further, reduced CRF immunoreactivity in the PVN and ACN may imply alterations of neuroendocrine, autonomic as well as central functions caused by MPTP.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine↗

PubMed1995

Visual hemineglect induced by unilateral striatal dopamine deficiency in monkeys.

Unilateral dopamine deficiency of the basal ganglia produced a profound impairment of visual search. Dopaminergic innervation of the monkey striatum was deprived unilaterally by infusing 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into the caudate nucleus. The monkeys were shown a mirror in which they saw their own image and surroundings. Compared with the concentric and symmetrical distribution of visual search before MPTP infusion, the gaze after MPTP infusion was confined and sometimes frozen in peripheral regions in the hemispace ipsilateral to the infusion; the contralateral side was largely neglected. An experiment using a choice saccade task indicated that the contralateral visual signal, which alone was processed normally, was suppressed by the ipsilateral signal.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine↗